Search for: "IN RE: REGLAN LITIGATION" Results 21 - 38 of 38
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jan 2012, 10:20 am by Max Kennerly, Esq.
In Mensing, Gladys Mensing was prescribed Reglan in 2001 and received generic metoclopramide from her pharmacist. [read post]
30 Apr 2014, 10:11 am
Thanks to Terry Henryat Blank Rome for sending along today’s preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation (No. [read post]
27 Oct 2011, 2:42 pm by FDABlog HPM
  Now, the RLD theory has taken center stage in the Court of Common Pleas of Philadelphia County in In re: Reglan/Metoclopramide Litigation. [read post]
15 Aug 2016, 8:13 am by Michael Grossman
Thanks to the ruling, the majority of generic drug manufacturers are immune to litigation in the event their products cause harm to their users, as long as they don’t deviate from the labels of the name-brand drug. [read post]
18 Nov 2014, 11:16 am
  None of them very long (at least by DDLaw Blog standards), but we think that each will be of interest to at least some our readers.On Generic Plaintiffs’ Preemption “Win” in New JerseyThis piece is from the non-Dechert side of the blog.Plaintiffs alleging failure to warn of the risks of a generic drug scored a “win” of sorts in In re Reglan Litigation, 2014 WL 5840281 (N.J. [read post]
30 Jun 2011, 3:00 am by Robert Kraft
… The Supreme Court has sent a loud and clear message to the American people: ‘You’re out of luck and on your own. [read post]
29 Jun 2011, 3:12 am by Bob Kraft
… The Supreme Court has sent a loud and clear message to the American people: ‘You’re out of luck and on your own. [read post]
29 Jun 2011, 3:17 am by Bob Kraft
Studies had suggested a potentially increased risk of the condition - and Reglan was eventually required to carry a 'black box' warning about it. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
8 May 2012, 5:59 pm by FDABlog HPM
The most recent rejection of the RLD theory of liability comes out of the Superior Court of New Jersey in In re Reglan Litigation, Case No. 289 (N.J. [read post]
13 Nov 2008, 1:52 pm
The PDR compiles FDA-approved drug labeling, id. at *4 n.4 - the same sort of routine product warnings that have been the bread and butter of product liability liability litigation for decades. [read post]
31 Dec 2014, 5:00 am
  We’re celebrating the new year in our usual style, with our annual top ten best prescription medical product liability litigation decisions of 2014. [read post]
5 May 2009, 5:57 am
District Court, Southern District of Indiana (Indianapolis); and In re Seroquel Products Litigation, 06-MD-01769, U.S. [read post]
28 Nov 2009, 7:11 am by Beck/Herrmann
Mensing, like almost all the recent branded/generic cases, involves Wyeth's drug Reglan - also sold generically as metoclopramide. [read post]